INBS vs. DXR, BDMD, SPAI, MODD, ECOR, PYPD, POCI, NMTC, DRIO, and COCH
Should you be buying Intelligent Bio Solutions stock or one of its competitors? The main competitors of Intelligent Bio Solutions include Daxor (DXR), Baird Medical Investment (BDMD), Safe Pro Group (SPAI), Modular Medical (MODD), electroCore (ECOR), PolyPid (PYPD), Precision Optics (POCI), NeuroOne Medical Technologies (NMTC), DarioHealth (DRIO), and Envoy Medical (COCH). These companies are all part of the "medical equipment" industry.
Intelligent Bio Solutions vs. Its Competitors
Intelligent Bio Solutions (NASDAQ:INBS) and Daxor (NASDAQ:DXR) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their valuation, institutional ownership, earnings, media sentiment, risk, profitability, analyst recommendations and dividends.
Intelligent Bio Solutions has a beta of 4.6, meaning that its share price is 360% more volatile than the S&P 500. Comparatively, Daxor has a beta of -0.07, meaning that its share price is 107% less volatile than the S&P 500.
Daxor has lower revenue, but higher earnings than Intelligent Bio Solutions.
33.0% of Intelligent Bio Solutions shares are owned by institutional investors. Comparatively, 1.3% of Daxor shares are owned by institutional investors. 1.5% of Intelligent Bio Solutions shares are owned by insiders. Comparatively, 59.5% of Daxor shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.
Daxor has a net margin of 0.00% compared to Intelligent Bio Solutions' net margin of -319.85%. Daxor's return on equity of 0.00% beat Intelligent Bio Solutions' return on equity.
Daxor has a consensus price target of $25.00, indicating a potential upside of 154.32%. Given Daxor's stronger consensus rating and higher probable upside, analysts plainly believe Daxor is more favorable than Intelligent Bio Solutions.
In the previous week, Intelligent Bio Solutions' average media sentiment score of 0.00 equaled Daxor'saverage media sentiment score.
Summary
Daxor beats Intelligent Bio Solutions on 7 of the 10 factors compared between the two stocks.
Get Intelligent Bio Solutions News Delivered to You Automatically
Sign up to receive the latest news and ratings for INBS and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding INBS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Intelligent Bio Solutions Competitors List
Related Companies and Tools
This page (NASDAQ:INBS) was last updated on 7/5/2025 by MarketBeat.com Staff
